Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
44.8%
% of PBE's 29 holdings also in FBT
43.3%
% of FBT's 31 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
BIOMARIN PHARMACEUTICAL INC | 5.3% | 3.6% | 3.6% |
|
UNITED THERAPEUTICS CORP | 5.4% | 3.4% | 3.4% |
|
REGENERON PHARMACEUTICALS | 5.1% | 3.3% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 5.4% | 3.2% | 3.2% |
|
GILEAD SCIENCES INC | 5.3% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to FBT
|
VERICEL CORPORATION | 3.2% |
|
INTRA-CELLULAR THERAPIES INC | 3.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.0% |
|
MYRIAD GENETICS INC | 3.0% |
|
VERACYTE INC | 3.0% |
|
REPLIGEN CORP | 2.9% |
|
CATALYST PHARMACEUTICAL PART | 2.8% |
|
HALOZYME THERAPEUTICS INC | 2.8% |
|
DYNAVAX TECHNOLOGIES CORP | 2.7% |
|
OPKO HEALTH INC | 2.6% |
PBE Underweight Relative to FBT
 |
GRIFOLS SA-ADR | -3.9% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.8% |
|
IQVIA HOLDINGS INC | -3.7% |
 |
BIONTECH SE SPONSORED ADR | -3.6% |
|
IONIS PHARMACEUTICALS, INC. | -3.5% |
 |
GENMAB A/S SPONSORED ADR | -3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.5% |
|
CHARLES RIVER LABORATORIES | -3.5% |
 |
ARGENX SE ADR | -3.4% |
|
AGIOS PHARMACEUTICALS INC | -3.4% |